Changes

5,699 bytes added ,  05:14, 5 October 2023
no edit summary
Line 85: Line 85:     
== Research works with their outcome on Matra Basti ==
 
== Research works with their outcome on Matra Basti ==
 +
{| class="wikitable"
 +
|+'''Research works on matra basti:'''
 +
!'''S.no.'''
 +
!'''Title'''
 +
!'''Authors'''
 +
!'''Research place'''
 +
!'''Method & Observation'''
 +
!'''Conclusion'''
 +
|-
 +
|1
 +
|A clinical study of Nirgundi Ghana  Vati & matra basti in the management of Gridhrasi w.s.r. to Sciatica. <sup>[8]</sup>
 +
|Mumtaz Ali, V D Shukla, A R Dave, N  N Bhatt
 +
|Outpatients and inpatients of  Kayachikitsa and Panchakarma Department, Institute of post graduate teaching  and research in Ayurveda, Jamnagar
 +
|
 +
=== 1]mild improvement –group A-  59.52%    group B-52% ===
 +
 +
=== 2]moderate improvement –group A-  26.8%    group B-32% ===
 +
 +
=== 3]marked improvement –group A-  13.44%    group B-18% ===
 +
|In  this research, total 119 patients diagnosed with sciatica. Better results  were obtained in patients who underwent matra basti rather than Nirgundi Ghan  alone.
 +
|-
 +
|2
 +
|
 +
= Clinical effect of Matra Basti and Vatari  Guggulu in the management of Amavata (rheumatoid arthritis).'''<sup>[9]</sup>''' =
 +
|Rita Khagram Charmi S  Mehta, V D  Shukla, Alankruta  R Dave
 +
|OPD and IPD Kayachikitsa and  Panchakarma Department, Institute of post graduate teaching and research in  Ayurveda, Jamnagar
 +
|In ''Matra Basti'' group, 52%; 26  patients showed marked improvement, while in the ''Vatari  Guggulu'' group 54.72%; 29 patients showed mild improvement.
 +
|
 +
=== Total  103 patients completed the treatment for Amavata. Better results were obtained in  patients who underwent Matra Basti rather than Vatari Guggulu alone. ===
 +
|-
 +
|3
 +
|A clinical evaluation of Kanchanar Guggulu and Bala Taila Matra Basti in the  management of Mutraghata with special reference to benign prostatic  hyperplasia. <sup>[10]</sup>
 +
|
 +
=== Gajiram  Dharamdas ===
 +
Banothe , Vyasdeva  Mahanta <sup>,</sup> Sanjay  Kumar Gupta , Tukaram  S Dudhamal
 +
|IPGT & RA department of Shalya tantra,  Jamnagar.
 +
|Group A- ''Bala Taila''  ''Matra Basti'',
 +
 +
Group B- ''Bala Taila'' ''Matra Basti'',  and ''Kanchanara Guggulu'' Vati  administered for 21 days.
 +
|Total 32 patients were participated in this  study.
 +
 +
''Matra basti'' along with ''Kanchanara  Guggulu'' orally showed comparatively better symptomatic  relief as compared to ''Matra Basti'' alone in cases  of ''Mutraghata'' (BPH).
 +
|-
 +
|4
 +
|
 +
= Efficacy of Kanchanara Guggulu and Matra Basti  of Dhanyaka Gokshura Ghrita in Mootraghata (benign prostatic hyperplasia). =
 +
'''<sup>[11]</sup>'''
 +
|Joyal Kumar K Patel , Tukaram S Dudhamal, Sanjay Kumar Gupta, Vyasadeva Mahanta
 +
|OPD and IPD of Shalya Tantra, Jamnagar.
 +
|Group A- Kanchanara Guggulu (500 mg, 3 times  a day orally),
 +
 +
Group B- Dhanyaka Gokshura Ghrita Matra  Basti,
 +
 +
Group C- Kanchanara Guggulu + Dhanyaka  Gokshura Ghrita Matra Basti for 21 days.
 +
 +
1)Maximum improvement- 33.34%, 55.56% and  33.34% of patients in Group A, Group B and Group C, respectively.
 +
 +
2)Moderate improvement- 44.44% of patients in  all three groups.
 +
 +
3)The mild improvement -11.11% and 22.22% in  Group A and Group C, respectively
 +
|Total 30 diagnosed patients of BPH were  selected. They underwent intervention and found maximum imrprovement with  Matra Basti
 +
|-
 +
|5
 +
|
 +
= Gokshuradi Vati and Dhanyaka-Gokshura Ghrita  Matra Basti in the management of Benign Prostatic Hyperplasia. '''<sup>[12]</sup>''' =
 +
 +
 +
|Shreyas G Bhalodia , Chaturbhuj Bhuyan , Sanjay Kumar Gupta, Tukaram S Dudhamal
 +
|OPD and IPD of Shalya Tantra, Jamnagar.
 +
|
 +
=== 10  in each group, 21 days of treatment regimen ===
 +
 +
=== Group  A-''Gokshuradi'' compound  ''Vati'' 500 mg  three times a day with luke-warm water after food; ===
 +
 +
=== Group  B- ''Dhanyaka-Gokshura Ghrita'' as ''Matra Basti'' of 60 ml,  once in a day, and combined therapy of both formulations in ===
 +
 +
=== Group  C- ''Gokshuradi'' compound  ''Vati'' + ''Dhanyaka-Gokshura Ghrita'' as ''Matra Basti'' of 60 ml was  administered. ===
 +
45.67% improvement was seen in group A,  47.99% in group B, and 54.09% was seen in group C. The size of prostate gland  was found reduced highly significant in group C.
 +
|Maximum improvement was found in the Matra  Basti group.
 +
|-
 +
|6
 +
|A comparative study of Dashamoola Taila Matra Basti and Tila  Taila Matra Basti in Kashtartava (dysmenorrhea). '''<sup>[13]</sup>'''
 +
|Kaumadi  Karunagoda , Kamayani  Shukla Upadhyaya, Shilpa  Donga, Chandrika  Tanna, L P Dei
 +
|Department of Striroga and Prasuti Tantra,  IPGT and RA, Gujarat Ayurved University, Jamnagar.
 +
|
 +
=== For  the present study, only primary dysmenorrhea was considered under ''Kashtartava''. ===
 +
|''Tila taila matra basti'' and ''dashamoola taila matra basti'' are  both highly effective in primary dysmenorrhea ''(kashtartava). Dashamoola Taila  Matra Basti'' also helps to prevent recurrence of  dysmenorrhea.
 +
|-
 +
|7
 +
|
 +
= Role of Nasya and Matra Basti with Narayana  Taila on anovulatory factor. '''<sup>[14]</sup>''' =
 +
|Krupa R  Donga , Shilpa  B Donga, Laxmi  Priya Dei
 +
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
 +
|''22 patients were  completed the study (11 in each group).''
 +
|''Matra Basti'' provides significant results over ''Nasya'' on anovulatory factor.
 +
|-
 +
|8
 +
|Effect of shatapushpa taila matra basti and pathadi kwatha on  poly cystic ovarian disease. '''<sup>[15]</sup>'''
 +
|Krupa D  Patel , Laxmipriya  Dei, Shilpa  B Donga, Nalini  Anand
 +
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
 +
|Group 1- 14 patients (''Pathadi Kwatha Churna)''
 +
 +
Group 2- 12 patients shatapushpa taila matra  basti (STMB)
 +
 +
Group 2 provided  statistically better results  in regularizing menstruation, achieving  considerable reduction in body weight, substantial growth of follicles, and  thus ovulation.
 +
|Treatment with the combination of both ''Pathadi  Kwatha'' and Matra Basti has additional effect on the symptoms  of PCOD.
 +
|}